← Back to Search

Insulin Pump

Sensor Augmented Pump Therapy for Cystic Fibrosis

N/A
Waitlist Available
Led By Christine Chan, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 24 hours of admission
Awards & highlights

Study Summary

This study is evaluating whether a new method of insulin delivery may help improve blood sugar control for individuals with cystic fibrosis.

Eligible Conditions
  • Cystic Fibrosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 24 hours of admission
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 24 hours of admission for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Differences in CGM percent time over 140 mg/dl
Secondary outcome measures
Change in Pulmonary Function
Circulatory markers of inflammation
Statstrip glucose
+1 more
Other outcome measures
beta-cell function

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard of Care and CGMExperimental Treatment1 Intervention
Group II: Insulin Pump and CGMExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sensor Augmented Pump Therapy
2016
N/A
~110

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,582 Total Patients Enrolled
16 Trials studying Cystic Fibrosis
892 Patients Enrolled for Cystic Fibrosis
Cystic Fibrosis FoundationOTHER
189 Previous Clinical Trials
37,209 Total Patients Enrolled
182 Trials studying Cystic Fibrosis
34,272 Patients Enrolled for Cystic Fibrosis
Christine Chan, MDPrincipal Investigatorchristinel.chan@childrenscolorado.org

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management
2020. "Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03939065.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top